View
50
Download
0
Category
Tags:
Preview:
DESCRIPTION
Department of Pediatric Radiology / Villa Metabolica. Whole body MRI technique in early treated non- neuronopathic patients with enzyme replacement therapy at least eight years. Larissa Moos, Jörg Reinke, Miriam Brixius -Huth, Eugen Mengel and Gundula Staatz - PowerPoint PPT Presentation
Citation preview
Whole body MRI technique in early treated non-neuronopathic patients with enzyme replacement therapy at least eight years
Larissa Moos, Jörg Reinke, Miriam Brixius-Huth, Eugen Mengel and Gundula Staatz
Department of Pediatric Radiology and Villa MetabolicaMainz Germany
Department of Pediatric Radiology / Villa Metabolica
2
Introduction
• 3rd EWGGD in Lemnos: – Initiation of high dose ERT followed be
individual adapted maintenance dosage inchildren ( signs of GD in preschool age)
– n=10, age: 6-10 years, ERT follow up: – 6 years
• 10th EWGGD in Paris– Same cohort ( + 5 pts, 1 pts lost to follow up )– 13 years later
3
Most of these Patients > 50 yearsWhat about red marrow and yellow marrow in young adults?Can we prevent bone disease ?
MOTIVATION
4
AIM OF THE STUDY
To show the outcome of early treated patients with treatment initiation before the age of 10
years after 8 – 20 years of ERT, when they become young adults.
5
• Inclusion Criteria:a) Typ 1 GD is confirmed, clinical relevant manifestationb) Treatment initiation before the age of 10! c) Treated since a minimum of 8 years
• ∑ 14 patients• Age of 17- 26 years• Mainzer treatment protocol is used
Patients
6
Initial:• Clinical manifestions
before the age of 10 years!
• Advice: 60 IE/kg KG / 14 days
Maintenence:• Permanent therapy to
prevent detoriation and complications
• Advice: 15-60 IE/kg KG/14 days
• Mainzer Protocol: Dosage depends on clinical symptoms and increase of chitotriosidase!Average: 38.5 IE/kg KG/14 days
TRETAMENT PROTOCOL FOR ERT
7
Outcome Measures
Bone-marrow Scores – Whole body MRI:
• Düsseldorfer Gaucher Score (DGS)
• Vetebra-Disc-ratio (VDR)
• Bone Marrow Burden Score (BMB)
All-domain- Score:
• Sverity Score Index Type 1 (GD-S3)
8
VDR, BMB, & DGS-Scores
Source : vom Dahl S. et al. Cur Med Res Opin 2006;22:1045-1064
9
• Includes only lower extremities
• Differentiates between A-&B Pattern
• Bone infiltration always bilateral
• A maximum of 8 points can obtained
DGS-SCORE
Source: Poll et al. (2003)
10
Normal:• hyperintense-signal intensity
(T1-sequence)/ fine- structured
Source: Institut für Kinderradiologie, Johannes-Gutenberg-Universität
GRADUATION OF BONE-MARROW INFILTRATION
Low:• mostly hyperintense-signal intensity
with beginng of Gaucher-cell infiltration→hypointense (T1) /regular-structured
Medium:• more hypointense-signal intensity/
regular structured
High:• severe hypointense-signal intensity/ inhomogenous
11
Joint destruction
FractureBone pain
Short stature
Osteopenia/Osteoporosis
Bone infarct
Early beginning with ERT could prevent BONE COMPLICATIOS
Bone complications
0/14
0/140/14
0/14
0/14 0/14
12
GD-S3 Scoring System
Source: Weinreb N, et al. Gen Med 2010;12:44–51
9-16
VAS
0/141/14
0/14
0/14
0/14
0/14
13
Median Q25 Q75 Range
Bone-marrow-Score:
BMB-Sc.: 7 6 8,26 3-11
DGS-Sc.: 4A 4A 4A 3-5 A-B
VDR-Sc.: 1,33 1,05 1,59 1,19-2,01
All- Domain-Score:
GD-S3 1,6 1,6 1,6 0-2,26
Score-classifications:
• BMB-Sc.: 0-4 (mild)/ 5-8 (moderate)/ 9-16 (severe) [Range: 0-16]• DGS-Sc.: 1-6 (low)/ 7-8 (high) compared with type A & B-morphology [Range: 1-8]• VDR-Sc.: 1.9 ±0.30 (normal)/ 1.29 ± 0.31 (untreated pat.)/ 1.7. ± 0.33 (long-treated
pat.)
Results
14
Vertebra-Disc-Ratio
Untreated Patient Long-treated Patient
15
Social aspects
• 8 pts with high school degree• 1 pts still in high school• 5 pts with jobs in offices or trades• 4 pts had there own family: 7 healthy ERT-
babies• No hospitalisation
16
• All Whole- Body-MRIs were well tolerated
• NO BONE COMPLICATIONS
• Typical manifestions of GD are reduced to a minimum!• Only bone marrow infiltration was observed
• BMB-Score
• DGS-Score LOWER LEVEL
• GD-S3 Score
• VDR-Score EXCEPTION: located in the spectrum of non-treated pat.
• Postponed bone marrow conversion ?? Minimum effective dose ??
Consequence: Follow-up studies
Conclusion
17
Thanks
• Patients• Larissa Moss• Cooperation: Prof. G. Staatz, Pediatric
Radiology Mainz• Team of the Villa metabolica
18
• Maas, M.; van Kuijk, C.; Stoker, J.; Hollak, C. E. M.; Akkerman, E. M.; Aerts, J. F. M. G.; den Heeten, G. J. (2003):Quantification of Bone Involvement in Gaucher Disease: MR Imaging Bone Marrow Burden Score as an Alternative to Dixon Quantitative Chemical Shift MR Imaging--Initial Experience.In: Radiology 229 (2), S. 554–561.
• Poll, Ludger W.; Cox, Marie-Louise; Godehardt, Erhard; Steinhof, Verena; Vom Dahl, Stephan (2011):Whole body MRI in type I Gaucher patients: Evaluation of skeletal involvement.In: Blood Cells, Molecules, and Diseases 46 (1), S. 53–59.
• Weinreb, Neal J.; Cappellini, Maria D.; Cox, Timothy M.; Giannini, Edward H.; Grabowski, Gregory A.; Hwu, Wuh-Liang et al. (2009):A validated disease severity scoring system for adults with type 1 Gaucher disease.In: Genet Med 12 (1), S. 44–51.
• Di Rocco, M.; Giona, F.; Carubbi, F.; Linari, S.; Minichilli, F.; Brady, R. O. et al. (2008):A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease.In: Haematologica 93 (8), S. 1211–1218.
• http://radiopaedia.org/encyclopaedia/quizzes/all/8366• http://www.primary-surgery.org/ps/vol2/html/sect0322.html• http://www.123rf.com/photo_11530363_human-knee-pain-running-man-skeleton-x-ray-visual-bone-health-fitness-exercise-chart-
symbol.html• http://seekingalpha.com/article/175098-growth-report-for-third-quarter-2009-part-i
References
19
MAINZER TREATMENT PROTOCOL
Recommended